HER2/neu testing for anti-HER2-based therapies in patients with unresectable and/or metastatic gastric cancer Academic Article uri icon

Overview

MeSH Major

  • Receptor, ErbB-2
  • Stomach Neoplasms

abstract

  • HER2 gene amplification is significantly associated with patient survival. HER2 gene amplification approaches might be an optimal HER2/neu testing strategy for the selection of HER2+ GC patients who are candidates to be treated with anti-HER2 therapies.

publication date

  • August 2012

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3410298

Digital Object Identifier (DOI)

  • 10.1136/jclinpath-2012-200774

PubMed ID

  • 22569536

Additional Document Info

start page

  • 751

end page

  • 7

volume

  • 65

number

  • 8